Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study (CIN3+plus)

University of Bern

Status: Completed

Conditions: Cervical Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT02323997

CIN3+plus

Details and patient eligibility

About

This study will investigate the types of HPV in samples from women with cervical pre-cancer and cancer and gather information to help investigate the impact of HPV vaccination in Switzerland.

Enrollment: 767 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participant is willing and able to give informed consent for participation in the study.
• Participant is literate in German, French, Italian or English.
• Female, aged 18 years or above.
• Histologically confirmed CIN3+ lesions, i.e. CIN3, adenocarcinoma in situ and invasive carcinoma of the cervix.
• Participant resides in the canton Zurich, Geneva, Basel, Baselland, Luzern or Ticino.

Exclusion criteria

• None